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Summary 
The outer surface proteins (Osps) of Borrelia  burgdotferi,  the etiologic agent of Lyme disease,  are 
principle targets of protective immune responses against this organism. Whereas most North 
American strains of B.  burgdotferi  in culture express an abundant amount of Osp A, antibodies 
to this protein are either absent or only weakly detected in the sera of naturally infected patients 
or experimentally infected mice. In contrast, Osp C, which has variable expression on cultured 
organisms, elicits  an early, strong humoral response. To examine this paradox, we have studied 
the  in  vivo  adaptation  of a  cloned  population  of B.  burgdotferi  strain  N40  during  the  early 
course of experimental murine borreliosis. As in human disease, antibodies to Osp A were only 
weakly present in the  early immune repertoire after murine inoculation with low dose (103) 
spirochetes. In contrast, antibodies to Osp C  were prominent, even though on cultured spiro- 
chetes  Osp C  mRNA and protein expression could not be detected by reverse transcription 
polymerase chain  reaction  (RT-PCR)  or indirect  immunofluorescence,  respectively.  These 
observations led us to investigate the expression ofOsp A and Osp C in vivo. By direct fluores- 
cent  staining  of uncultured  spirochetes  ex  vivo  and  by  PCR  amplification  of spirochetal 
mRNA, we show that Osp C  is indeed  expressed by some spirochetes after infection in the 
mouse. Spirochetes expressing Osp A could also be detected within the first 2 wk of infection, 
but not at 30 d. Osp A mRNA, although present at day 14 of infection, could not be amplified 
by RT-PCR at day 30, suggesting that the expression of this Osp is transient. This further im- 
plies that the  late burst in  Osp A  antibodies  in  both mice and  humans  may be anamnestic. 
These results indicate that either Osp C  is upregulated on spirochetes after infection,  or Osp 
C-expressing spirochetes expand preferentially over those expressing Osp A  during infection. 
These results have important implications for vaccine design and offer one explanation for the 
failure of Osp A antibodies to eradicate spirochetes from the infected host. 
L 
Yme disease,  caused by infection with the tick-transmit- 
ted spirochete Borrelia burgdoferi, is manifested by disease 
that reflects the in vivo migration of this  organism in  the 
mammalian host. After establishing infection in the skin at 
the site of the tick bite, a transient rash, erythema chronicum 
migrans, can appear and is the clinical  hallmark of Lyme dis- 
ease. Spirochetes subsequently become blood borne and re- 
sult in disease  manifestations of other organs, especially the 
heart, nervous system, and joints (1). Although most patients 
are readily cured by antibiotic therapy (1), rare patients have 
persistent or recurring Lyme disease, which can be severe and 
debilitating.  From the first description of the human disease, 
arthritis was observed to come and go, even though the pa- 
tient remained infected  (2).  Although  spirochetes become 
more difficult to find as the disease  progresses, there is rea- 
son to believe that they are driving the illness  throughout 
its course. Evidence in favor of a reservoir of live spirochetes 
in humans includes the expanding antigen specificity of im- 
mune sera from patients in later stages of disease,  suggesting 
newly exposed spirochetal epitopes (3),  and the occasional 
identification of spirochetes in organs clinically asymptom- 
atic (4) or affected in late stages of disease (5, 6).  In chroni- 
cally infected mice, despite resolution of their disease, spiro- 
chetes are still occasionally sighted and can be cultured from 
various organs.  And  despite  the  apparent dormancy of the 
spirochetes in their original murine host, they remain infec- 
tive for naive mice (7). 
Outer surface protein  (Osp) 1 A  is a major outer mem- 
1Abbreviations used in this paper: BSK II medium, Barbour-Stoener-Kelly 
II medium; NMS, normal mouse serum; cN40, Borrelia burgdo~ri strain 
N40; Osp, outer surface protein; RT, reverse  transcription. 
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stricto, the major genotype found in the United States (8). 
Humoral immunity to Osp A has been shown to be impor- 
tant  in protection  against  infection with  B.  burgdooeeri (9- 
12), and this antigen is now the basis of recombinant Lyme 
disease  vaccines.  Osp A  vaccination,  however,  even  24  h 
after introduction of the spirochete into the host, does not 
eliminate  infection  (13).  Furthermore,  naturally arising Osp 
A  antibodies are incapable of completely eradicating spiro- 
chetes from the infected host, but when passively supplied, 
some  sera  containing  Osp  A  antibodies  can protect naive 
mice  from challenge  infection  (14).  These  findings  suggest 
that  Osp  A  expression  on  spirochetes  may  change  during 
mammalian infection.  The inability  to visualize  organisms 
by immunofluorescence in infected tissues  and the paucity 
of organisms in general has made analysis of this question dif- 
ficult.  Organisms  recultured  from  infected  animals  have 
identical protein and genetic make-up to the original infect- 
ing spirochetes (15); this observation may be due to in vitro 
growth  conditions  favoring reversion  to  the  phenotype  of 
the original culture. 
Patients with Lyme disease rarely have detectable serum an- 
tibodies to Osp A during the first few months of untreated in- 
fection. A striking finding has been the consistent, strong early 
antibody response to Osp C, a 22-kD lipoprotein, which, in 
contrast to Osp A, has variable expression on cultured B. burg- 
do~ri (16-20). Over time, a small proportion of patients, gen- 
erally those with chronic arthritis, seroconvert to Osp A  (21). 
Mice experimentally infected by tick challenge or syringe in- 
oculation with low numbers of spirochetes (< 104) readily de- 
velop Osp C antibodies but do not have detectable IgG anti- 
bodies to Osp A until 6 mo or later in the course of infection 
(22, 23).  Several hypotheses have been proposed to explain 
the Osp A  antibody response:  (a) Osp A  antibodies may be 
sequestered in immune complexes (24); (b) sufficient T  cell 
help  to promote B  cell antibody production is not present 
(Bockenstedt,  L. K., E.  Fikrig,  S. W. Barthold,  R. A. Fla- 
yell,  and  F.  S.  Kantor,  manuscript  submitted  for publica- 
tion); and (c) Osp A  may be downregulated on spirochetes 
either in the  tick or after transmission  to the host  (25a,b). 
Although evidence  is  available  to  support  all  of these  hy- 
potheses, little is known about the proteins expressed on B. 
burgdooeeri in vivo in the mammalian host. The present stud- 
ies using a cloned population orB. burgdooCeri  were designed 
to  investigate  the  paradox  of the  Osp  A  and  Osp  C  hu- 
moral response. 
Using  a  well-characterized  cloned  population  of spiro- 
chetes, we investigated Osp A and Osp C  expression early in 
the  course  of B.  burgdo~feri infection in mice.  Infecting or- 
ganisms  expressed  high  levels  of Osp  A  on  their  surfaces, 
whereas  Osp  C  expression  could  not  be  detected  at  the 
mRNA  or protein level.  In contrast to the cultured organ- 
isms, some spirochetes obtained from the peritoneal cavities 
of infected mice and examined directly expressed Osp C but 
not Osp A. Osp A+/Osp C- spirochetes were still visualized 
at day 14, but were not detected at day 30. The immunofluo- 
rescent  data were  supported by mRNA  analysis  of Osp  A 
and  Osp  C  expression  at  infection  days  14  and  30.  These 
studies indicate that after infection,  Osp C  expression is ei- 
ther upregulated,  or a minor population of Osp C-express- 
ing spirochetes preferentially expands in the infected host. In 
contrast, Osp A-expressing spirochetes appear to diminish in 
number so that by day 30, they are below the level of detec- 
tion.  These  findings  may help  to  explain  the  antibody re- 
sponses to these  Osps in the  early phases  of infection,  and 
they offer one explanation for the failure of Osp A  antibod- 
ies to effectively clear spirochetes from the infected host. 
Materials  and Methods 
Mice.  Pathogen-free weanling female  C3H/HeJ  (H2  k) mice 
were purchased from The Jackson Laboratory (Bar Harbor, ME). 
Mice were shipped in filter-equipped  crates  and housed in mi- 
croisolator cages. Animals were provided food and water ad libi- 
turn and were  cared  for according to the PuNic  Health  Service 
guide for the care and use of laboratory  animals. Mice were killed 
with carbon dioxide gas. 
Spirodwtes.  A low in vitro passage of B. burgdooCeri  strain N40 
(cN40), which had been previously cloned and tested for infectivity 
and pathogenicity  (22), was used in all experiments. The spirochetes 
had been cloned by limiting dilution  culture in modified Barbour- 
Stoenner-Kelly II (BSK II) medium three times and then stored at 
-70~  Before each experiment,  an aliquot ofcN40 was grown to 
logarithmic phase in modified BSK II medium and counted in a 
hemocytometer under dark-field  microscopy. 
Immunofluorescent Staining.  Spirochetes from lavage fluids were 
labeled either after adherence to peritoneal macrophages on cov- 
erslips or on resuspension after pelleting. Macrophages  were plated 
as described in aMEM/10% FBS on 12-ram glass coverslips at 37~ 
and fixed  15-30 rain later to minimize phagocytosis  (26). Spiro- 
chetes to be labeled in suspension were tint pelleted  in an Eppen- 
dorfmicrocentrifuge for 2 min at room temperature and then re- 
suspended  in PBS (Ca  2+ and Mg  e+ free)  and fixed  in methanol 
(-20~  6 min) or 4% paraformaldehyde  in PBS +0.01% saponin 
(room temperature,  20 min) as described  (27). All samples were 
washed in PBS and then  incubated for 20 rnin  in PBS  supple- 
mented with  10% goat serum.  Primary antibody at a dilution of 
1:100  was added in PBS/10% goat serum for 1 h at room tem- 
perature,  samples were washed two times in PBS, and then incu- 
bated again for 20 rain in PBS/10% goat serum at room tempera- 
ture. Antibodies were visualized with F(ab)'2 fluorescein (FITC)- or 
rhodamine  (TRITC)-conjugated goat anti-rabbit  or anti-mouse 
secondary antibodies (Tago, Inc., Burlingame,  CA) diluted in PBS/ 
10% goat serum and incubated with the spirochetes for 1 h at room 
temperature.  Samples were mounted with  moviol (Calbiochem 
Corp.,  La Jolla,  CA) and examined on a microscope (Axioskop; 
Carl Zeiss, Inc., Thornwood, NY). 
Detection ofmRNA,  mRNA  from  cultured  cN40  was  pre- 
pared in the presence ofJ774 cells, a macrophage-like cell line, to 
simulate the in vivo conditions from which mRNA would be de- 
rived from infected tissues. 104 cN40 from culture were washed 
twice in PBS, mixed with 3 X 106j774 cells, centrifuged,  and the 
pellet was resuspended in 6 ml GIT buffer (4 M guanidine isothio- 
cyanate, 0.025 M sodium acetate,  pH 6.0, and 0.8% 2-ME). The 
DNA was first sheared by passing the solution  through a 23-gauge 
needle  10 times,  and then layered  onto 4 ml of cesium  chloride. 
The cesium chloride gradient was centrifuged at 32,000 rpm in an 
SW41  rotor  (Beckman  Inst.,  Inc.,  Fullerton,  CA)  for  18  h  at 
room temperature.  The RNA pellet  was then solubilized  in 300 
~1 0.3 M sodium acetate, pH 6, precipitated  with ethanol, washed 
once  in  80%  ethanol,  and  allowed  to  air  dry.  Complementary 
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action  volume)  with  random  hexamers  using  the  Superscript 
Preamplification System for First Strand cDNA Synthesis accord- 
ing to  the manufacturer's protocol  (GIBCO BRL,  Gaithersburg, 
MD).  One fifth of the  reaction volume was  amplified by PCR 
using oligonucleotide primers for flagellin, Osp A, and Osp C at a 
final concentration of 10  IxM  each  in the  presence  of 20  lnM 
dNTPs. PCR was carried out for 25 cycles, with each cycle con- 
sisting of initial template denaturation at 94~  for 1 rain, annealing 
at 50~  for 2 rain, and extension at 72~  for 3 rain. Amplication 
was  completed by a final incubation at 72~  for  10  min.  10  Ixl 
out of a  100-1xl  reaction volume were  analyzed by agarose  gel 
electrophoresis  for  the  predicted product.  As  controls  for  DNA 
contamination, identical first-strand synthesis reactions were per- 
formed in the absence of reverse transcriptase (RT)  (Superscript 
II,  RT,  GIBCO  BRL).  mRNA  from  infected tissues  was  ob- 
tained both by the method described above (4 ml GIT/heart or 
lavage sample) as well as by using the Tri-Reagent RNA isolation 
kit  (Molecular Research  Center, Inc., Cincinnati, OH)  following 
the manufacturer's recommendations. RT-PCR  of infected tissue 
specimens was performed identically to  that  described above for 
cultured  organisms,  except  that  actin  was  amplified  instead  of 
flagellin. The sequences of primers and predicted amplified product 
sizes  are  as  follows:  5'  flagellin AGAGAATTCAGGAGAATT- 
TATGATTATCAATCATAATAC; 3'  flagellin TGTTTTGT- 
CATTGCTTAGATAAGGATCCTCT  (1,038  bp);  5'  Osp  A 
CCGGGATCCATATGGCTAAGCAAAATGTTAGC; 3'  Osp 
A  AACGCTTTAAAATAAAGATCTAGATATC (801  bp);  5' 
Osp  C  CGCGGATCCAATAATTCAGGG; 3'  Osp  C  CCA- 
AAAAAACCTTAAGAATTCGCG (590 bp); and 5' actin GTG- 
GGCCGCTCTAGGCACCA; 3'  actin CCCCCCTGAACCC- 
TAAGGCCAACC (245 bp). All primers were either made at the 
Oligonucleotide Synthesis laboratories at Yale University or were 
obtained commercially (actin primers; Stratagene Inc., LaJolla, CA). 
Immunoblotting.  Recombinant Osp A strain N40 prepared ac- 
cording to the method ofDunn et al. (28) was used. Recombinant 
Osp C, N40, was generated first as a fusion protein with glutathione 
transferase  using the pGEX-2T expression vector (Pharrnacia Fine 
Chemicals, Piscataway, NJ) and then cleaved from the fusion part- 
ner using thrombin as described (20). Spirochetal lysates were pre- 
pared by washing bacteria twice in PBS, fi'eeze-thawing once, then 
sonicating 10 times with 15-s pulses at 60% power. The recombi- 
nant proteins or cN40 lysates  were heated to  100~  for 5 rain in 
SDS sample buffer (50 mM Tris/C1, pH 6.8, 100 mM dithiothrei- 
tol, 2% SDS, 0.1% bromophenol blue, 10% glycerol) before separa- 
tion by SDS-PAGE. Electrophoresed proteins were then transferred 
to  nitrocellulose using a  minigel system  (Bio Rad  Laboratories, 
Hercules, CA). The strips were blocked with 5% nonfat dry milk 
in PBS, and primary antibodies were added at a  1:1,000 dilution 
of normal or immune mouse serum or 1:1,000 dilution of hyper- 
immune polyclonal antisera to rOsp A or rOsp C. The nitrocellu- 
lose  strips were  incubated for  2  h  with primary antibodies and 
then washed three times in PBS +  0.1% Tween 20 (PBST). The 
strips  were incubated for 2  h  with a  1:5,200 dilution of alkaline 
phosphatase-labeled goat anti-mouse IgM or IgG antibodies (Hy- 
clone Laboratories, Inc., Logan UT). After three 10-rain washes in 
PBST,  the  strips  were  developed  with  nitroblue  tetrazolium 
5-bromo 4-chloro-indolyl phosphate. 
Results  and Discussion 
We  first  characterized  the  expression  of Osps  A  and  C 
on low passage  cultured spirochetes  (previously cloned by 
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Figure  1.  Osp A but not Osp  C  can be detected  by immunoblot of 
cN40 lysates with polyclonal antisera to rOsps A and C. (Lane 1) Immu- 
noblot ofrOsp C with normal mouse serum (1:100).  (Lanes 2 and 3) Im- 
munoblots of rOsp A and cN40 lysate, respectively, with polyclonal anti- 
Osp A antisera (1:1,000).  (Lanes 4 and 5) Immunoblot of rOsp  C  and 
cN40 lysate, respectively, with polyclonal anti-Osp C antisera (1:1,000). 
Lane  1 is representative  of similar immunoblots of rOsp  A and cN40 
with NMS. 
limiting dilution) by three methods:  immunoblot of spiro- 
chetal  lysates,  mRNA  analysis, and indirect immunofluo- 
rescence  of whole  spirochetes.  Immunoblots  of lysates  of 
cN40  (equivalent  to  2  X  l05  spirochetes  per  lane)  were 
performed  using polyclonal antisera  generated  against  re- 
combinant Osp A  or Osp  C  (Fig.  1). Whereas  Osp A  was 
readily visualized (Fig.  1,  lane 3),  Osp  C  expression could 
not be detected  (Fig.  1, lane 5),  even though both antisera 
readily  bound  their  rOsp,  respectively  (rOsp  A,  lane  2; 
rOsp C, lane 4). To simulate the conditions under which B. 
burgdotferi  mRNA  would  be  detected  in  infected  tissues, 
mRNA  was  derived from  104  cN40  mixed with 3  X  106 
J774 cells, a macrophage cell line, as a source for eukaryotic 
RNA.  RT-PCR  performed on  10 gtg of RNA  easily am- 
plified both flagellin and Osp A  mRNA  (Fig. 2, lanes 6 and 
7,  respectively), but no product could be detected for Osp 
C  (Fig.  2,  lane  8).  By  indirect  immunofluorescence, cul- 
tured  N40  spirochetes  (grown  in BSK  II  medium and la- 
beled as described [28]) were brightly stained with antibod- 
Figure 2.  mRNA for flageUin  and 
Osp  A, but not for Osp  C,  can be 
detected  by RT-PCR  on cultured 
cN40.  mRNA  isolated  from  cul- 
tured spirochetes was  used  to  pro- 
duce  first-strand  cDNA  using  ran- 
dom  hexamers  as  described  in 
Materials  and  Methods.  Flagellin, 
Osp  A,  and  Osp  C  cDNAs  were 
amplified by PCR and analyzed by 
agarose gel electrophoresis. (Lane 1) 
High  molecular  weight  marker 
(HindlII digest of X bacteriophage; 
New England Biolabs, Inc., Beverly, 
MA).  (Lane  2)  Low  molecular 
weight  marker  (HAEIII  digest of 
qbX174;  New  England  Biolabs, 
Inc.).  (Lanes 3-5)  PCR  of mock 
first-strand reactions using flagellin- (lane 3), Osp A- (lane 4), and Osp 
C- (lane 5) specific primers. (Lanes 6-8) PCR of cDNA using flagellin- 
(lane 6), Osp A- (lane 7), and Osp C- (lane 8) specific primers. Predicted 
sizes of amplified products are flagellin, 1,038 bp; Osp A, 801 bp; and Osp 
C, 590 bp. Figure 3.  Spirochetes ex vivo can express either Osp A or Osp C. Peritoneal lavage fluids from infected rmce were isolated on days 7, 14, and 30 after 
infection with B. burgdotferi. Spirochetes were fixed and double labeled with mouse serum directed against rOsp C  and rabbit antisera directed against ei- 
ther Osp A  or against cN40 organisms. Labeling was performed both in suspension and on adherent macrophages as described previously. Images were 
viewed under oil immersion and photographed at X 100.  (A and/3)  Cultured N40 spirochetes. (C-F)  Spirochetes recovered from infected animals by 
peritoneal lavage. FITC (A, C, and E) labels Osp C, and TRITC (B, D, and F) labels Osp A or N40. ies directed against Osp A  (Fig.  3 B; T1KITC), but had little 
or no detectable labeling with antibodies directed against Osp 
C  (Fig. 3 A; FITC). Taken together, these three methods of 
evaluating protein expression strongly indicate that Osp A 
but not Osp C was present at significant levels on this cloned 
population of spirochetes. 
Spirochetes are rarely sighted in an infected animal, and 
recovery from organs such as skin or heart in sufficient num- 
bers for study is unlikely. In the course of our macrophage 
studies (27), however, we were able to reculture spirochetes 
from peritoneal lavage fluids of mice infected for 60 or 90 d 
after intradermal inoculations of 103 or 10  s cN40 spirochetes. 
The uninflamed peritoneum provides extensive surface area 
for a reservoir of spirochetes, and our reculture data suggests 
that the site may be immunoprivileged, in the sense that res- 
ident macrophages in the peritoneal cavity do not completely 
clear the  spirochetes, which  they ingest and kill rapidly in 
vitro  (27).  We  recognized  that  these  results  provided  us 
unique  access to  a  source  of tissue-adapted spirochetes in 
their in vivo state. By limiting dilution analysis, we estimated 
the recovery of  spirochetes from lavage fluids of  infected mice 
to  be  a  minimum  of 5-10  organisms per  animal  (n  =  5 
quantitative recoveries). In this study, spirochetes were re- 
covered directly from lavage fluids in  13 of 14 experiments, 
and could be detected equally well by immunofluorescence 
using  anti-N40  hyperimmune  serum  from  experiments 
performed at days 7,  14, and 30 after inoculation. 
We have used these organisms to analyze in vivo spirochetal 
protein expression. Spirochetes were labeled after fixation, 
either adherent, using peritoneal macrophages to capture spi- 
rochetes, or in suspension.  Organisms were double labeled 
to determine protein expression profiles and to garner more 
information from the limited material. Indirect immunofluo- 
rescence of fixed, cultured spirochetes in the presence ofmac- 
rophages revealed that Osp A expression (Fig. 3 B; TRITC) 
was readily apparent, whereas Osp C  staining was at the level 
of background  immunofluorescence  (Fig.  3  A;  FITC).  In 
contrast, some ex vivo spirochetes labeled distinctly for Osp 
C  (Fig.  3  E)  and not for Osp A  (Fig.  3  F).  Osp A-labeled 
spirochetes  (Fig.  3  D)  that did not bind Osp C  antibodies 
(Fig.  3  C) were also present. These findings were consistent 
for spirochetes obtained from animals killed at 7  and  14  d 
after infection  (n  =  3  each)  and show that  in vivo, some 
spirochetes can express either Osp C  or Osp A. At day 30 
of infection,  however,  only Osp  C-expressing spirochetes 
were visualized. Staining patterns were identical using dif- 
ferent fixation techniques (paraformaldehyde with or with- 
out methanol or saponin to permeabilize), whether B.  burg- 
dofferi were captured on macrophage monolayers or stained 
in  suspension,  whether antibodies  used were  of mouse or 
rabbit origin,  and whether secondary reagents were  FITC 
or TR.ITC (data not shown). Preincubating cultured spiro- 
chetes  with  either mouse serum or anticoagulated  mouse 
blood before fixation  and  antibody labeling  did  not  alter 
our ability to stain with Osp A  or N40 antisera, indicating 
that endogenous mouse antibodies, which could potentially 
bind to spirochetes in vivo (29),  are not likely to contribute 
to the immunofluorescence observed. Spirochetes cultured 
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from lavage fluid obtained from mice infected for 30 d and 
regrown to confluence in BSK II medium labeled only with 
reagents directed against Osp A, not Osp C, corresponding 
to the phenotype of in vitro cultured spirochetes labeled si- 
multaneously (data not shown). 
To determine how the spirochete appears to the immune 
system in these infected mice, sera were analyzed for the pres- 
ence of Osp A  and C  antibodies by immunoblotting rOsp 
A  and C. Weak IgM antibodies to Osp A  were greatest at 
day 28  (Fig.  4 A), the latest time point in this experiment, 
whereas IgG antibodies were at the threshold level of de- 
tection.  In contrast,  IgM and IgG Osp C  antibodies were 
present  at  day  14  of infection  (data  not  shown)  and  were 
strongly represented at day 28 (Fig.  4 B). These results sup- 
port the immunofluorescence data indicating that both Osp 
A- and Osp C-expressing spirochetes are present at some 
time before (and, in the case of Osp C, including) day 28 of 
infection. They also suggest that the late appearance of lgG 
Osp A antibodies, which occurs both in mice and in humans, 
may be anamnestic rather than a primary immune response. 
To confirm our morphological and immunological obser- 
Figure  4.  Osp C  elicits stronger humoral immunity than does Osp A. 
Sera from mice killed at 28 d of  infection were analyzed for IgM and lgG 
antibodies to Osp A and Osp C by immunoblot. (A) Iramunoblot ofrOsp 
A with  1:100  dilution ofsera from individual mice (lanes  1-I0) using al- 
kaline  phosphatase-conjugated  goat  anti-mouse  IgM-  or  IgG-specific 
secondary antibodies.  (/3) Immunoblot of rOsp  C  using the same sera. 
Negative and positive controls using NMS  (-)  and polyclonal anti-Osp 
A or C antisera (+) are as indicated. vations, we prepared mRNA  from lavage fluid of similarly 
infected mice and attempted to detect Osp A and C  mRNA 
by RT-PCR,  but were hampered by the small numbers of 
organisms and hence B.  burgdo~eri mRNA recovered, espe- 
cially in  relation  to  the  abundant  eukaryotic mRNA.  We 
therefore prepared total RNA  from the hearts of mice that 
were  killed  14 and 30  d  after inoculation  with  103 cN40. 
Hearts were chosen as a source for RNA because spirochetes 
can be visualized at this site by silver stain during periods of 
disease activity (30).  First-strand DNA was synthesized us- 
ing random hexamers  and 5  ~xg RNA  as template  in each 
50-1xl  reaction  volume.  Mock  first-strand  reactions  were 
performed in which the reaction components were assem- 
bled  and  incubated  in  the  absence  of Superscript RT  and 
then used as templates for PCR to analyze for the presence of 
contaminating DNA in the RNA  preparation.  PCR  of 10 
txl of the first-strand reaction using primers for the eukary- 
otic RNA  actin and  B.  burgdorferi~specific  primers for Osps 
A  and C  were carried out in an identical fashion as for cul- 
tured  organisms.  Amplified  products  of the  expected  size 
could be detected in both the Osp A  (Fig.  5 A, lane  5) and 
Osp C  reactions (Fig. 5 A, lane 8), consistent with the pres- 
ence ofmRNA  for these proteins in day-14 infected hearts. 
RT-PCR  of uninfected  heart  mRNA  yielded  a  product 
only for actin  (data  not shown).  Whereas  Osp  C  mRNA 
could be detected  in day-30 hearts by this  method  (Fig.  5 
B, lane  8),  no  amplified  Osp A  product was visualized  by 
agarose gel electrophoresis under identical conditions (Fig.  5 
B,  lane  5;  n  =  3).  Because  the  RT-PCR  reactions  were 
performed  on  similar  amounts  of mRNA  derived  from 
hearts  at days  14 and 30 of infection,  these  results  strongly 
suggest that the relative  amount of Osp A  mRNA  has di- 
minished over time. 
Taken  together,  our studies  demonstrate  that  14 d  after 
syringe  inoculation  with  a  clonal  population  of Osp  A+/ 
Osp  C-  spirochetes,  both  Osp  C+/Osp  A-  and  Osp A+/ 
Osp C- spirochetes are present in the murine host. Because 
these studies were not performed in a quantitative  fashion, 
we cannot determine  the absolute abundance of each type 
of spirochete.  Although it is possible  that a rare spirochete 
within the original inoculum expressed Osp C, the fact that 
such a spirochete  could be visualized ex vivo and that Osp 
C  mRNA  could be detected from RNA  isolated from in- 
fected  tissues  but  not  from  RNA  of cultured  organisms 
indicates  that  either  Osp  C  is  upregulated  or  that  Osp 
C-expressing  spirochetes  have  a  selective growth advantage 
over Osp A-expressing spirochetes in the mammalian host. 
Other  investigators  have  detected  Osp  C  expression  on 
cultured  spirochetes,  including  N40,  by immunoblot  (16, 
18,  19).  Several proteins comigrate around the 22-kD region 
on  electrophoresis  of spirochetal  lysates  and  using  Borrelia- 
infected mouse or human sera to identify their presence does 
not  distinguish  reactivity  to  Osp  C  with  antibodies  to 
other,  similarly  located  proteins  on  one-dimensional  gels. 
Immunoblotting with antisera produced against rOsp  C  is a 
more specific method of detecting the presence of Osp C. 
Lysates  generated  from  nonclonal  populations  of  spiro- 
chetes  could  contain  spirochetes  with  mixed  phenotypes, 
Figure 5.  mRNA for Osp C persists for at least 30 d whereas that for 
Osp A does not. mRNA isolated from infected hearts (A, infection day 
14, B, infection day 30) was used to produce first-strand cDNA using ran- 
dom hexamers as described in Materials and Methods. Actin, Osp A, and 
Osp C cDNAs were amplified by PCR and analyzed by agarose gel dec- 
trophoresis. (Lanes 1 and 10) 1-kb ladder (Gibco Laboratories, Grand Is- 
land, NY). (Lanes 2, 5, and 8) PCR of cDNA using actin- (lane 2), Osp 
A- (lane 5), and Osp C- (lane 8) specific  primers. (Lanes  3, 6, and 9) PCR 
of mock first-strand reactions using actin- (lane 3), Osp A- (lane 4), and 
Osp C- (lane 5) specific primers. Positive controls for PCR are products 
from amplification ofOsp A and C genes subcloned into Bluescript II KS 
(lanes 4 and 6, respectively). Predicted sizes of amplified products are ac- 
tin, 245 bp; Osp A, 801 bp; and Osp C, 590 bp. 
some of  which could express Osp C. In addition, Osp C  ex- 
pression may be stress  related  (31),  so that even clonal cul- 
tures grown to late log phase  (which simulates a stress  con- 
dition)  could possibly upregulate  Osp  C.  For these reasons, 
we used a  clonal population of N40 in our studies,  and ly- 
sates for immunoblots were made from a defined number of 
spirochetes in logarithmic phase of growth.  Osp C  expres- 
sion was absent not only by immunoblot,  but also by RT- 
PCR  for  mRNA  and  by  immunofluorescent  staining  of 
fixed spirochetes.  Taken together,  these  three  complemen- 
tary methods, 'although individually not conclusive, strongly 
suggest that the spirochetes used in our studies  did not ex- 
press significant amounts of Osp C  in culture. 
Our results performed in the mammalian host are consis- 
tent with those found by Schwan et al.  (31) in similar studies 
carried out in the tick.  Infected flat (i.e.,  unfed)  ticks con- 
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antibodies directed against Osp  C, but rather were visual- 
ized using reagents directed against  Osp A. In contrast, after 
feeding, both Osp A and C  expression could be detected on 
midgut spirochetes. These authors also show that Osp C  ex- 
pression on cultured organisms varied with temperature, with 
spirochetes grown at 24~  producing no Osp  C, whereas 
those grown at 37~  rapidly upregnlate this protein. Spiro- 
chetes grown at 37~  were a phenotypically mixed popula- 
tion, with some expressing only Osp A, some only Osp C, 
and some both proteins. In our studies,  spirochetes obtained 
from peritoneal lavage fluids of infected mice expressed only 
Osp A or Osp C, but not both. The failure to detect Osp A+/ 
Osp  C+spirochetes may be due to the relatively low abun- 
dance of organisms in the lavage fluid. 
The studies reported here do not differentiate between se- 
lective pressure for expansion of a particular clone of B. burg- 
do~feri and true antigenic variation of the organism after in- 
fection. We have therefore referred to our results as antigenic 
substitution, which covers both possibilities.  It has been sug- 
gested that Osp C expression may be necessary for infectivity 
and that exposure to mammalian blood may influence its reg- 
ulation (32). 14 d after intradermal syringe inoculation of  spi- 
rochetes into the shoulder region, we found both Osp A+/ 
Osp C- and Osp C+/Osp A- spirochetes in the peritoneal 
cavities of infected mice. Presumably, these spirochetes ar- 
rived in the peritoneal cavity via a blood-borne route. Unless 
antigenic variation is occurring, this finding suggests that both 
types of  spirochetes are capable of disseminating  from the ini- 
tial inoculation site and can exist simultaneously at the higher 
core temperature of the mouse. 
We began these investigations to explain why Osp A an- 
tibodies are absent or only weakly detected in patients with 
early Lyme disease. We have shown elsewhere that priming 
mice with a single Osp A Th cell epitope before infection by 
syringe inoculation results  in earlier IgG seroconversion to 
Osp A than would normally occur during infection (Bock- 
enstedt, L. K., E. Fikrig, S. W. Barthold, 1Z. A. Flavell, and 
F.  S.  Kantor, manuscript in preparation). When serocon- 
version occurred, it could be detected within the first 2 wk 
of infection;  longer experimental periods  did not  result in 
greater numbers of animals  seroconverting to Osp A. These 
findings suggest that the amount of Osp A present within the 
first several days of infection is a critical determinant of IgG 
antibody production, and they also indicate that Osp A an- 
tigen  becomes limiting  relatively soon  after infection.  In 
the current studies, we were able to detect Osp A on spiro- 
chetes both  by  immunofluorescence  and  at  the  mRNA 
level at day 14,  but not at day 30, of infection. The weak 
antibody response may therefore result,  in part,  from the 
transient expression of Osp A by spirochetes in the infected 
host. Downregulation of Osp A after infection is consistent 
with studies by Barthold et al.  (16),  in which mice immu- 
nized with Osp A were not protected from challenge infec- 
tion by transplantation of skin from syngeneic mice previ- 
ously infected with  104  B.  burgdotferi strain  N40.  In  the 
same studies,  the authors show that mice inoculated with 
107 heat-killed N40 seroconvert to Osp A, but not to 22- 
kD proteins, including Osp C. In contrast, mice inoculated 
with as few as  101 viable organisms seroconvert to Osp C 
(as well as other 22-kD proteins), but not to Osp A.  Our 
analysis of Osp  expression on tissue-adapted spirochetes at 
both the protein and mRNA level support these immuno- 
logic data, indicating that Osp C is expressed on spirochetes 
after infection and  that  Osp  A +  spirochetes become less 
readily apparent over time. 
To ensure its continued survival in nature, B.  burgdotferi 
must adapt readily to the disparate environments of its two 
major host reservoirs,  ticks and mammals. One way in which 
B. burgdorferi may accomplish this is to vary its expression of 
characteristic surface proteins. Variation of Osps by infec- 
tious agents is well documented both in spirochetes and other 
microorganisms (32).  For example, the related spirochete, 
Borrelia hermsii,  the causative agent of relapsing fever; varies 
its major surface protein by gene rearrangements (33),  and 
Serpulina  hyodysenteriae  has strain-specific expression of an 
important virulence determinant (34). In B. burgdo{feri, varia- 
tions in expression are known at the mR.NA level (35) and 
protein level (36) and after prolonged in vitro culture (37). 
Other possible mechanisms for changing protein expression 
are downregnlation or shedding of characteristic proteins in 
vivo, or covering characteristic  proteins with a "slime layer" 
of spirochete or of host origin (30, 38). 
Taken together, the results  presented in this study dem- 
onstrate that C3H mice infected by syringe inoculation with 
B.  burgdotferi strain N40 spirochetes expressing only Osp A 
are exposed to and mount an early immune response to both 
Osp A and Osp C, although the former protein elicits a much 
weaker response.  Our  investigations indicate  that  Osp  A 
expression diminishes during early infection, providing one 
explanation for the weaker antibody response to this pro- 
tein. Moreover, our close study of spirochetes ex vivo is the 
first  indication that Osp  C-expressing spirochetes expand 
preferentially over those expressing Osp A in the mamma- 
lian host. These findings suggest a previously unrecognized 
role for Osp C  in spirochetal adaptation and survival in the 
mammalian host. 
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